GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » YoY EBITDA Growth

Kineta (STU:J75) YoY EBITDA Growth : -13.87% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Kineta's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -13.87%.

Kineta's EBITDA per Share for the three months ended in Mar. 2024 was €-0.82.


Kineta YoY EBITDA Growth Historical Data

The historical data trend for Kineta's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta YoY EBITDA Growth Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
- -521.99 -438.90 90.03

Kineta Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.38 103.53 59.96 97.86 -13.87

Kineta YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Kineta's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-1.139--11.43)/ | -11.43 |
=90.03 %

Kineta's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-0.821--0.721)/ | -0.721 |
=-13.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kineta YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Kineta's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Kineta (STU:J75) Business Description

Traded in Other Exchanges
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines